Cynthia Sirard
Chief Tech/Sci/R&D Officer chez LEAP THERAPEUTICS, INC.
Fortune : 13 300 $ au 31/03/2024
Profil
Cynthia Sirard is currently the Chief Medical Officer at Leap Therapeutics, Inc. She started this position in 2020.
Previously, she worked as a Medical Director at PAREXEL International Corp from 2003 to 2005.
Dr. Sirard completed her undergraduate degree at the University of Massachusetts and obtained her doctorate from Chicago Medical School.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
LEAP THERAPEUTICS, INC.
0,02% | 29/01/2024 | 5 000 ( 0,02% ) | 13 300 $ | 31/03/2024 |
Postes actifs de Cynthia Sirard
Sociétés | Poste | Début |
---|---|---|
LEAP THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Anciens postes connus de Cynthia Sirard
Sociétés | Poste | Fin |
---|---|---|
PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Formation de Cynthia Sirard
University of Massachusetts | Undergraduate Degree |
Chicago Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LEAP THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
PAREXEL International Corp.
PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |